IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ligand Pharmaceuticals Inc

Q4 2013 vs Q1 2014

Comparing institutional holders between quarters

Quarters

Q1 2014Q4 2013Q3 2013Q2 2013
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
Benchmark Capital Advisors
DECREASED
Shares20,800 from 25,000
Change-4,200 (-17%)
Value$1.4K (+$84)
Filed 2014-04-16
Baker Bros. Advisors LP
CLOSED
Shares0 from 73,400
Change-73,400 (-100%)
Value$0 (-$3.9K)
Filed 2014-05-15
Status
Benchmark Capital Advisors
DECREASED20,80025,000-4,200-17%$1.3K$1.4K+$842014-04-16
Baker Bros. Advisors LP
CLOSED073,400-73,400-100%$3.9K$0-$3.9K2014-05-15
Showing 2 of 2 institutions